Nippon Genetics and Bulldog Bio Create Alliance in North America
News Jul 18, 2013
Nippon Genetics Europe GmbH and Bulldog Bio have penned an agreement that assigns Bulldog Bio the sole right to sell many of Nippon Genetics’ electrophoresis and cell biology products to researchers in the USA.
Bulldog Bio in return will support, market, and stock their products.
“We’ve already seen early success with researchers adopting Nippon Genetics’ safe alternative to ethidium bromide which we began to sell early in the year.”
Ella Fontaine VP of Communications further elaborates “The feedback from many customers regarding Nippon Genetics wonderful line up of products has convinced us that there are many more labs that can benefit from these novel tools.”
The terms of this exclusive distribution contract have not been disclosed.
LifeArc Becomes Technology Transfer Partner to London School of Hygiene & Tropical MedicineNews
LifeArc, the medical research charity, has partnered with London School of Hygiene & Tropical Medicine to provide a range of services in technology transfers.READ MORE
Human Pluripotent Stem Cells Successfully 3D PrintedNews
A breakthrough in the 3D-printing of human pluripotent stem cells means scientists are one step closer to being able to 3D print human organs and tissues for transplantation therapy.READ MORE
Acquisition Sees Agilent Gain Powerful NGS IP PortfolioNews
Agilent Technologies announces its acquisition of the molecular and sample barcoding portfolios of Population Genetics Technologies.READ MORE
Comments | 0 ADD COMMENT
International Conference on Genomics and Pharmacogenomics
Jul 18 - Jul 19, 2018